GW-870086 is a glucocorticoid receptor agonist potentially for the treatment of asthma and atopic dermatitis.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | GW-870086 is a glucocorticoid receptor agonist potentially for the treatment of asthma and atopic dermatitis. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00945932 | Asthma | Phase 2 | Completed | - | Germany ... 展开 >> GSK Investigational Site Ruedersdorf, Brandenburg, Germany, 15562 GSK Investigational Site Frankfurt, Hessen, Germany, 60596 GSK Investigational Site Mainz, Rheinland-Pfalz, Germany, 55131 GSK Investigational Site Geesthacht, Schleswig-Holstein, Germany, 21502 GSK Investigational Site Berlin, Germany, 10367 GSK Investigational Site Berlin, Germany, 10717 GSK Investigational Site Berlin, Germany, 10787 GSK Investigational Site Berlin, Germany, 14057 收起 << |
NCT00857857 | Asthma | Phase 2 | Completed | - | Germany ... 展开 >> GSK Investigational Site Wiesbaden, Hessen, Germany, 65187 GSK Investigational Site Hannover, Niedersachsen, Germany, 30625 GSK Investigational Site Grosshansdorf, Schleswig-Holstein, Germany, 22927 GSK Investigational Site Berlin, Germany, 14050 收起 << |
NCT01160003 | Asthma | Phase 1 | Completed | - | Germany ... 展开 >> GSK Investigational Site Berlin, Germany, 14050 收起 << |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
1.79mL 0.36mL 0.18mL |
8.93mL 1.79mL 0.89mL |
17.87mL 3.57mL 1.79mL |
CAS号 | 827319-43-7 |
分子式 | C31H39F2NO6 |
分子量 | 559.64 |
SMILES Code | C[C@@]12[C@](C(OCC#N)=O)(OC(C3C(C)(C)C3(C)C)=O)[C@H](C)C[C@@]1([H])[C@]4([H])C[C@H](F)C5=CC(C=C[C@]5(C)[C@@]4(F)[C@@H](O)C2)=O |
MDL No. | N/A |
别名 | |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry, 2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|